| 发明名称 |
4-[2-[[5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE SALTS |
| 摘要 |
600310 The present disclosure relates to 4-[-2-[[5-methyl-1 -(2-naphthalenyl)-1 H-pyrazol-3- yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases. |
| 申请公布号 |
NZ600310(A) |
申请公布日期 |
2013.08.30 |
| 申请号 |
NZ20100600310 |
申请日期 |
2010.11.25 |
| 申请人 |
LABORATORIOS DEL DR. ESTEVE S.A. |
发明人 |
SOLA - CARANDELL, LLUIS;GARCIA - COUCEIRO, URKO;CUBERES-ALTISENT, MARIA ROSA |
| 分类号 |
A61K9/16;A61K31/4152;A61P25/00;C07D231/22 |
主分类号 |
A61K9/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
